Ken Griffin's position in Viridian Therapeutics is currently worth $38.6M. That's 0.02% of their equity portfolio (752nd largest holding). The investor owns 2.58% of the outstanding Viridian Therapeutics stock. The first Viridian Therapeutics trade was made in Q1 2021. Since then Ken Griffin bought shares ten more times and sold shares on nine occasions. The investor's estimated purchase price is $51.7M, resulting in a loss of 25%.